BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19503102)

  • 21. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
    Tao ZW; Huang YW; Xia Q; Xu QW
    Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arjunolic acid, a peroxisome proliferator-activated receptor α agonist, regresses cardiac fibrosis by inhibiting non-canonical TGF-β signaling.
    Bansal T; Chatterjee E; Singh J; Ray A; Kundu B; Thankamani V; Sengupta S; Sarkar S
    J Biol Chem; 2017 Oct; 292(40):16440-16462. PubMed ID: 28821620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Puerarin ameliorated pressure overload-induced cardiac hypertrophy in ovariectomized rats through activation of the PPARα/PGC-1 pathway.
    Hou N; Huang Y; Cai SA; Yuan WC; Li LR; Liu XW; Zhao GJ; Qiu XX; Li AQ; Cheng CF; Liu SM; Chen XH; Cai DF; Xie JX; Chen MS; Luo CF
    Acta Pharmacol Sin; 2021 Jan; 42(1):55-67. PubMed ID: 32504066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACE inhibition reduces left ventricular mass independent of pressure without affecting coronary flow and flow reserve in spontaneously hypertensive rats.
    Kaneko K; Susic D; Nunez E; Frohlich ED
    Am J Med Sci; 1997 Jul; 314(1):21-7. PubMed ID: 9216436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension.
    Iglarz M; Touyz RM; Amiri F; Lavoie MF; Diep QN; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):45-51. PubMed ID: 12524223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway.
    Li H; Lu W; Cai WW; Wang PJ; Zhang N; Yu CP; Wang DL; Liu BC; Sun W
    Pulm Pharmacol Ther; 2014 Jun; 28(1):17-24. PubMed ID: 24269521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of vascular angiotensin-converting enzyme by telmisartan via the peroxisome proliferator-activated receptor gamma agonistic property in rats.
    Takai S; Jin D; Kimura M; Kirimura K; Sakonjo H; Tanaka K; Miyazaki M
    Hypertens Res; 2007 Dec; 30(12):1231-7. PubMed ID: 18344629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.
    Xia QG; Reinecke A; Dorenkamp M; Storz C; Bitterling H; Penz S; Cleutjens J; Daemen MJ; Simon R; Unger T
    Acta Pharmacol Sin; 2004 Jun; 25(6):763-8. PubMed ID: 15169629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxisome proliferator ameliorates endocardial endothelial and muscarinic dysfunction in spontaneously hypertensive rats.
    Smiley LM; Camp TM; Lucchesi PA; Tyagi SC
    Antioxid Redox Signal; 2004 Apr; 6(2):367-74. PubMed ID: 15025938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
    Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H
    Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction.
    Kompa AR; Lu J; Weller TJ; Kelly DJ; Krum H; von Lueder TG; Wang BH
    Int J Cardiol; 2018 May; 258():192-198. PubMed ID: 29544929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
    Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination.
    Tsuchida A; Yamauchi T; Takekawa S; Hada Y; Ito Y; Maki T; Kadowaki T
    Diabetes; 2005 Dec; 54(12):3358-70. PubMed ID: 16306350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Shiomi T; Tsutsui H; Hayashidani S; Suematsu N; Ikeuchi M; Wen J; Ishibashi M; Kubota T; Egashira K; Takeshita A
    Circulation; 2002 Dec; 106(24):3126-32. PubMed ID: 12473562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure.
    Gundewar S; Calvert JW; Jha S; Toedt-Pingel I; Ji SY; Nunez D; Ramachandran A; Anaya-Cisneros M; Tian R; Lefer DJ
    Circ Res; 2009 Feb; 104(3):403-11. PubMed ID: 19096023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astragalus polysaccharides repress myocardial lipotoxicity in a PPARalpha-dependent manner in vitro and in vivo in mice.
    Chen W; Lai Y; Wang L; Xia Y; Chen W; Zhao X; Yu M; Li Y; Zhang Y; Ye H
    J Diabetes Complications; 2015 Mar; 29(2):164-75. PubMed ID: 25499591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACE inhibition decreases postoperative mortality in rats with left ventricular hypertrophy and myocardial infarction.
    Linz W; Wiemer G; Schmidts HL; Ulmer W; Ruppert D; Schölkens BA
    Clin Exp Hypertens; 1996 Jul; 18(5):691-712. PubMed ID: 8781754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reduction.
    Linz W; Gohlke P; Unger T; Schölkens BA
    Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():31-4. PubMed ID: 7646309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction.
    Linz W; Itter G; Dobrucki LW; Malinski T; Wiemer G
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):180-5. PubMed ID: 14608524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats.
    Linz W; Schaper J; Wiemer G; Albus U; Schölkens BA
    Br J Pharmacol; 1992 Dec; 107(4):970-5. PubMed ID: 1334756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.